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Introduction
============

The three-dimensional organization of DNA within the nucleus is related to chromatin function, and the genomic DNA is organized and actively positioned within the nuclear space ([@bib17]). Nucleosome packaging and histone modification have been implicated in chromatin domain positioning ([@bib60]; [@bib10]; [@bib67]; [@bib63]), but the precise mechanisms determining physical organization of chromosomes are not well understood.

Telomeres are the nucleoprotein structures that protect chromosome ends from degradation and ensure the telomerase-mediated length maintenance of the terminal repeat sequences. The organization of the telomeres of budding yeast *Saccharomyces cerevisiae* offers a useful model system to study chromosome localization ([@bib17]). The 32 telomeres of haploid yeast cells are organized in three to six clusters at the nuclear periphery ([@bib22]). *S. cerevisiae* subtelomeric sequences are subject to transcriptional silencing ([@bib24]) and replicate late during S phase ([@bib49]). Recombination between telomeres and other chromosomal loci is suppressed ([@bib48]). Therefore, budding yeast telomeres are "insulated" from other chromosomal regions both spatially and functionally.

Two partially redundant pathways have been identified that mediate tethering of telomeres to the nuclear periphery: the Sir4-dependent and Ku-dependent pathways ([@bib29]; [@bib59]). Sir4 is a telomere-binding protein that, along with Sir2 and Sir3, is essential for transcriptional silencing of telomere-proximal genes. Sir4 tethers telomeres to nuclear periphery through interactions with Esc1 and Mps3 on the nuclear membrane ([@bib59]; [@bib6]). The Ku protein complex is a heterodimer consisting of Yku70 and Yku80, which binds to telomeres and is essential for their late replication ([@bib12]), as well as playing a major role in telomere length regulation ([@bib47]). The Ku heterodimer can also mediate peripheral tethering of telomeres, but the interaction partner of Ku on the nuclear membrane has not yet been identified. Mutants lacking both Ku and Sir4 function show random positioning of all telomeres tested, but single mutants compromise the peripheral localization of different telomeres to different extents, which suggests that the 32 telomeres vary in their dependence on the two pathways for peripheral tethering ([@bib7]). Telomere peripheral tethering is cell cycle--regulated: telomeres generally show perinuclear localization in G1 and S phases but not in G2 or M phases.

Telomeres are not the only genomic sequences to show localization to the nuclear periphery. Other yeast genomic loci that display peripheral localization include transcriptionally activated *GAL1* and *INO1* genes ([@bib5]; [@bib8]; [@bib52]), and in *Schizosaccharomyces pombe*, the so-called "chromosome-organizing clamp" (COC) sites that behave as insulator elements ([@bib44]). *S. cerevisiae HMR*-silenced chromatin is also peripherally localized, and Sir4 and Ku proteins contribute to *HMR* localization and confinement of its mobility within the nuclear space ([@bib16]). Therefore, mechanisms involved in telomere localization may act more generally in subnuclear organization, and identification of the factors involved in telomere localization may provide insight into mechanisms controlling the subnuclear organization of other chromosome sites.

Asf1 is an evolutionarily conserved histone H3--H4 complex (H3--H4) chaperone that is implicated in several chromatin-remodeling pathways ([@bib42]). Asf1 is involved along with other histone chaperones in both replication-independent and replication-coupled histone deposition pathways ([@bib42]). Asf1 stimulates acetylation of the histone H3 lysine 56 (H3K56) and loading of H3 acetylated at K56 into newly assembled chromatin ([@bib50]; [@bib54]), acting along with the histone chaperones CAF-1 and Rtt106, which preferentially load H3 acetylated at K56 during replication-coupled chromatin assembly ([@bib36]). Asf1 is also required under certain circumstances for integrity of the replication machinery ([@bib42]), and the replicative clamp-loading complex replication factor C binds Asf1 and can recruit it to DNA in vitro ([@bib15]). These observations strongly suggest that Asf1 acts in replication-coupled histone deposition through direct interaction with the replication machinery. Asf1 has also been implicated in telomere-specific chromatin organization because either disruption or overexpression of *ASF1* causes defective transcriptional silencing at telomeres ([@bib56]).

Rap1 is a telomere-binding protein involved in telomere length regulation and recruitment of the Sir protein complex to telomeres ([@bib34]). Here, we have used GFP-Rap1 as a marker protein to screen for mutants with defective telomere organization. After secondary testing of these mutants, we identified eight new genes that are required for telomere localization to the nuclear periphery. The genes identified suggest that an event in S phase is important for telomere localization. In particular, we identify the chromatin-packaging histone chaperone Asf1 as one of the components required for telomere localization, and show that its stimulation of H3K56 acetylation is crucial for correct telomere positioning at the nuclear periphery. We demonstrate the existence of a peripherally localized *S. cerevisiae* COC site, and show that its positioning also depends on H3K56 acetylation. Collectively, our results suggest that H3K56 acetylation is crucially important for correct three-dimensional organization of chromosomes within the nucleus.

Results
=======

Rap1 organization mutants
-------------------------

To identify mutants defective in telomere localization, we used a candidate-based layered screening approach. Telomere repeat sequences contain multiple Rap1-binding sites, and in cells expressing a GFP-Rap1 fusion protein, telomere clusters are detected as bright fluorescent foci at the nuclear periphery ([@bib27]; [@bib31]). We began by screening for mutants defective in spatial organization of Rap1 in the nucleus. 262 knockout mutants in nonessential genes were selected for screening based on the proposed function of their gene products in chromosome metabolism processes such as telomere maintenance, transcriptional silencing, or DNA replication, recombination, or repair, as well as localization to nuclear membrane or nuclear periphery (Table S1, available at <http://www.jcb.org/cgi/content/full/jcb.200806065/DC1>).

We transformed this panel of mutants with an episomal plasmid expressing GFP-Rap1 ([@bib31]), and screened for those mutants that have aberrant Rap1 organization. The strains were observed microscopically, and each strain tested was categorized according to the type of GFP-Rap1 organization it displayed. Four different basic phenotypes were observed, as illustrated in [Fig. 1](#fig1){ref-type="fig"}.

![**Categories of mutants with defective Rap1 organization.** The four observed categories of Rap1 organization phenotype are illustrated in the top panels. W, WT-like (i.e., no distinct Rap1 organization defect); A, internal foci; B, diffused fluorescence in entire nucleus; C, larger number of foci mainly still localized at nuclear periphery. Microscopic images on the bottom show strains typical for each category: W, WT; A, *ace2*Δ; B, *ctf18*Δ; C, *chl1*Δ. Bar, 1 μm.](jcb1830641f01){#fig1}

Type W mutants displayed no significant difference from the wild type (WT), as would be expected if the mutation carried does not affect telomere localization or spatial Rap1 organization. 169 of the mutants tested fell in this category, and these mutants were not further examined.

For type A mutants, the internal Rap1 dots observed were similar to WT in number and intensity, but the dots were located in the interior of the nucleus rather than correctly positioned at the periphery. *ace2*Δ was a typical example of this mutant category. Mutants that are defective in perinuclear telomere localization but not in telomere clustering or length control may potentially fall in this category.

Type B mutants displayed loss of any obvious GFP-Rap1 dots. Typical examples of mutants falling in this category are *asf1*Δ and *ctf18*Δ. Various factors could cause this phenotype, such as telomere localization and/or clustering defects, severe telomere shortening causing loss of Rap1 binding sites, or a defect in telomere binding by Rap1. Partly because the Rap1 fluorescence of a single unclustered telomere is so weak as to be hardly detectable, the telomere localization phenotype cannot be unequivocally assessed for type B mutants on the basis of the Rap1 localization pattern alone, and requires further investigation (see the following sections).

Type C mutants displayed an increased number of Rap1 dots at nuclear periphery, with individual dots less intense than normal. Typical examples in this category are *chl1*Δ and *tdp1*Δ mutants. Mutants in this category are likely to be proficient in telomere localization to the nuclear periphery, with the mutant phenotype instead probably reflecting a defect in telomere clustering. However, mutants with a very severe telomere clustering defect may not fall in this category, because if a mutant exhibits a clustering defect so severe that GFP-Rap1 foci are not detectable, the mutant will be classified as type B.

Mutants of types A, B, and C were also numerically scored (1--3) for severity and uniformity of the phenotype. Mutants with a uniformly severe phenotype (i.e., the majority of the cells in the population displaying the defect) were assigned a score of 3. Mutants with less severe phenotypes and/or mutants in which only a small proportion of the population showed defects were given a lower score. The complete list of phenotype scores and assignments is shown in Table S1.

The exact nature of the defect in each mutant cannot be determined simply from the observed Rap1 organization patterns, and further tests were required to understand the nature of the abnormality and to ascertain whether telomere peripheral localization is compromised. We decided to examine type A and B mutants further, as well as mutants with mixed phenotypes that were partly A or B. Type B mutants were of particular interest because previously identified telomere localization-defective mutants (including *yku70*Δ and *sir4*Δ) fell into this category. A type B GFP-Rap1 pattern does not, however, necessarily imply a telomere localization defect, as this phenotype could be caused by other abnormalities (such as telomere shortening or a severe clustering defect). Type A mutants also display a phenotype that is suggestive of telomere mislocalization and were good candidates for further study, although this category is prone to false positives arising from technical difficulty in judging whether GFP-Rap1 dots located close to the poles in a z series are perinuclear. The type C pattern suggests proficient telomere localization to the nuclear periphery, and these mutants have not as yet been further examined. 23 phenotypically A, B, or "mixed" mutants with numerical scores of 2 or 3 were chosen for further investigation (listed in [Table I](#tbl1){ref-type="table"}).

###### Summary of Rap1 organization mutants further examined

  Gene      ORF name   Rap1 phenotype   Score
  --------- ---------- ---------------- -------
  *ACE2*    YLR131C    A                2
  *ASF1*    YJL115W    B                3
  *BRE2*    YLR015W    B                3
  *CSM4*    YPL200W    B                2
  *CTF18*   YMR078C    B                3
  *CTF4*    YPR135W    B                3
  *ELP3*    YPL086C    B                2
  *ELP4*    YPL101W    B                2
  *GBP2*    YCL011C    A                2
  *IMD4*    YML056C    A                2
  *JJJ1*    YNL227C    A/C              2
  *MRE11*   YMR224C    B                2
  *PGD1*    YGL025C    B                3
  *PHO23*   YNL097C    B                2
  *RAD27*   YKL113C    B                2
  *RRM3*    YHR031C    B                3
  *RSC2*    YLR357W    B                2
  *SIC1*    YLR079W    A/B              2
  *SIR3*    YLR442C    B                3
  *SPE1*    YKL184W    A                2
  *SWI3*    YJL176C    B                2
  *TEL1*    YBL088C    B                2
  *YKU80*   YMR106C    B                3

Mutants were categorized as described in the text. Only mutants with a phenotype score of 2 or 3 are listed for further examination.

Telomere localization mutants
-----------------------------

We wished to assess directly whether telomere peripheral localization was affected in the mutants chosen for further analysis. A telomere can be microscopically visualized using the "chromosome dot" system, in which a chromosome site is "tagged" using GFP-LacI bound to an array of *lacO* operator repeats inserted at the required locus ([@bib57]). Deletion alleles for the various genes were transferred into a strain background where the chromosomal locus 11 kb away from telomere XIV-left (XIV-L) is visualized using this chromosome dot technique ([Fig. 2 A](#fig2){ref-type="fig"}; [@bib29]). In the strain background used, the nuclear envelope is also marked using a GFP-fused allele of the nuclear pore component Nup49 ([@bib4]). Perinuclear telomere localization was then scored by means of the "three-zoning" method ([@bib59]). In brief, cells were scored only if the telomere "dot" was observed to be close to the equatorial region in a z stack of images ([Fig. 2 B](#fig2){ref-type="fig"}, left). If this criterion was met, localization of the telomere was then scored to one of three concentric zones with equal surface area ([Fig. 2 B](#fig2){ref-type="fig"}, right). If the telomere distributes randomly within the nucleus, localization to each zone will be 33.3%. Conversely, if the telomere is localized at the nuclear periphery, it will be scored predominantly in zone 1 (as for WT; [Fig. 2, A and C](#fig2){ref-type="fig"}). The cell cycle stage of individual cells was estimated according to bud size (see Materials and methods), and telomere localization in G1 and S phase cells was separately scored ([Fig. 2 C](#fig2){ref-type="fig"}). Cells in G2 and M phases were not counted because telomeres lose their nuclear peripheral tethering during these late cell cycle phases.

![**Chromosome dot assay identifies a mutant with defective telomere localization to the nuclear periphery.** (A) Typical images of WT and *rrm3*Δ strains with a chromosomal GFP tag 11 kb away from telomere XIV-L, seen as a bright dot. The strains also express Nup49-GFP to visualize nuclear membrane, seen as a dimmer ring. Differential interference contrast (DIC) images are shown on the left. Bars, 2 μm. (B) The zoning of images close to the equatorial plane is used to evaluate telomere localization. Localization of the GFP dot was scored against three concentric zones with equal surface area, as described in Materials and methods. (C) Telomere localization in the identified mutants, assessed separately for cells in G1 phase and S phase. The percentage of cells whose telomere XIV-L dot was peripheral (i.e., in zone 1) is plotted. The red line represents the distribution (33.3%) of a randomly positioned locus. WT values are also indicated (blue bar). For statistical details, see [Table II](#tbl2){ref-type="table"}.](jcb1830641f02){#fig2}

Using this assay, 8 of the 23 mutants were observed to have a telomere localization defect; these were *ctf18*Δ, *pgd1*Δ, *rrm3*Δ, *elp4*Δ, *tel1*Δ, *asf1*Δ, *mre11*Δ, and *sic1*Δ. The results for these mutants are presented in [Fig. 2 C](#fig2){ref-type="fig"}, which shows the percentage of telomeres observed at the nuclear periphery (i.e., in zone 1) for the telomere localization-defective strains. Statistical analysis of these mutants is summarized in [Table II](#tbl2){ref-type="table"}. Data for all the mutants tested (including those that were telomere localization-proficient) is summarized in Table S2 (available at <http://www.jcb.org/cgi/content/full/jcb.200806065/DC1>). *sir4*Δ and *yku70*Δ mutants were included in this analysis as controls because these mutants have previously been shown to display defective telomere localization ([@bib29]).

###### Summary of telomere localization mutants

  Mutant         ORF name   Rap1 phenotype   \% zone 1 (*n*,[a](#tblfn1){ref-type="table-fn"} p-value[b](#tblfn2){ref-type="table-fn"})                               
  -------------- ---------- ---------------- -------------------------------------------------------------------------------------------- --------------------------- -------------------------
  Controls                                                                                                                                                            
      WT                                                                                                                                  66.0 (295, 1.00)            67.5 (336, 1.00)
      *sir4*Δ    YDR227W    B                3                                                                                            46.0 (124, 1.5 × 10^−5^)    58.2 (91, 0.01)
      *yku70*Δ   YMR284W    B                3                                                                                            54.4 (184, 1.5 × 10^−4^)    55.7 (87, 2.5 × 10^−5^)
  G1 and S                                                                                                                                                            
      *ctf18*Δ   YMR078C    B                3                                                                                            40.2 (247, 5.3 × 10^−12^)   51.9 (212, 0.002)
      *pgd1*Δ    YGL025C    B                3                                                                                            37.9 (112, 3.5 × 10^−11^)   44.8 (95, 6.2 × 10^−7^)
      *rrm3*Δ    YHR031C    B                3                                                                                            45.2 (62, 0.002)            38.4 (86, 2.0 × 10^−8^)
  G1 specific                                                                                                                                                         
      *elp4*Δ    YPL101W    B/C              2                                                                                            45.7 (35, 0.01)             71.9 (32, 0.68)
      *tel1*Δ    YBL088C    B                2                                                                                            48.1 (54, 0.002)            63.0 (46, 0.80)
  S specific                                                                                                                                                          
      *asf1*Δ    YJL115W    B                3                                                                                            67.4 (46, 0.05)             43.1 (51, 4.7 × 10^−4^)
      *mre11*Δ   YMR224C    B                2                                                                                            59.4 (32, 0.66)             47.3 (55, 5.9 × 10^−4^)
      *sic1*Δ    YLR079W    A/B              2                                                                                            74.2 (31, 0.49)             50.0 (42, 0.002)
  Marginal                                                                                                                                                            
      *csm4*Δ    YPL200W    B                2                                                                                            56.8 (37, 0.31)             59.0 (39, 0.26)
      *jjj1*Δ    YNL227C    A/C              2                                                                                            52.3 (65, 0.03)             57.6 (39, 0.26)
      *sir3*Δ    YLR442C    B                3                                                                                            56.5 (46, 0.31)             54.5 (44, 0.07)

Localization of telomere XIV-L in each strain was measured as described in Materials and methods.

Total number of cells scored in each cell cycle phase.

Calculated by χ^2^ test against WT value.

Three of the mutants, *ctf18*Δ, *pgd1*Δ, and *rrm3*Δ, were found to be defective in telomere localization during both G1 and S phases. Each of the three mutations did, however, have slightly different impact on telomere localization at each cell cycle stage. Two mutants, *elp4*Δ and *tel1*Δ, are defective in G1 phase but not in S phase. Three mutations, *asf1*Δ, *mre11*Δ, and *sic1*Δ, have a distinct telomere localization defect in S phase, but no obvious defect in G1 phase. These cell cycle--specific defects of the various mutants suggest that different mechanisms are responsible for telomere localization in G1 and S phases.

3 of the 23 mutants, *csm4*Δ, *jjj1*Δ, and *sir3*Δ, displayed slight defects in telomere XIV-L peripheral localization in both in G1 and S phases. However, statistical analysis failed to demonstrate that these effects are significant ([Table II](#tbl2){ref-type="table"}).

Of the 23 mutants carried forward, 18 mutants were successfully examined for localization of telomere XIV-L by using the chromosomal GFP dot technique. Five of the mutants were left untested for technical reasons (see Table S2), usually because of difficulties in obtaining the required chromosome dot strains.

No correlation between telomere localization and telomere length
----------------------------------------------------------------

Some of the genes identified are implicated in telomere length regulation ([@bib3]; [@bib18]). To investigate whether telomere length directly regulates telomere localization, we measured telomere length in the localization mutants ([Fig. 3 A](#fig3){ref-type="fig"}). Telomeres in *mre11*Δ, *tel1*Δ, and *yku70*Δ mutants are significantly shorter than in WT. Although the effect is smaller, *ctf18*Δ, *pgd1*Δ, and *sir4*Δ mutants also have short telomeres. Subpopulations of *rrm3*Δ and *sic1*Δ mutants have abnormally long telomeres. No distinct effect on telomere length was observed in *asf1*Δ and *elp4*Δ mutants. These results are consistent with previously published data ([@bib3]; [@bib18]). To investigate any relationship between telomere localization and telomere length, telomere length was plotted against the "% zone 1" value for all the mutants tested for telomere localization ([Fig. 3 B](#fig3){ref-type="fig"}). For each mutant, the lower of the G1 and S phase localization values was used in this assessment. As shown in [Fig. 3](#fig3){ref-type="fig"}, no clear correlation between telomere length and localization proficiency was observed. Telomere length was also plotted against G1 and S phase localization values separately (Fig. S1, available at <http://www.jcb.org/cgi/content/full/jcb.200806065/DC1>). Again, no direct correlation between telomere length and telomere localization defect was observed. Because some mutants display short but well-localized telomeres, whereas others contain mislocalized telomeres of normal length, we conclude that telomere shortening is neither necessary nor sufficient to cause a telomere localization defect.

![**Telomere delocalization does not cause shortened telomeres, and short telomeres do not preclude peripheral localization.** (A) Telomere lengths of telomere localization-defective mutant strains were tested as described in Materials and methods. The result for *pgd1*Δ is from a different gel performed under identical condition to the others. Positions of molecular weight markers are shown on the left. The black line indicates that lanes have been spliced out. (B) Mean length of the terminal fragment derived from Y′ telomeres plotted against "% zone 1" value of each mutant. For all mutants, the "% zone 1" values differ in G1 and S phases; the lower value is shown. (e.g., for the *asf1*Δ mutant, "% zone 1" values in G1 and S phase are 67.4% and 43.1%, respectively; the value plotted is 43.1%.)](jcb1830641f03){#fig3}

Histone acetyltransferase Rtt109 is required for telomere localization
----------------------------------------------------------------------

The *asf1*Δ mutant displayed a severe telomere localization defect during S phase but had telomeres of normal length. Asf1 is a histone chaperone involved in assembling the histone H3--H4 subcomplex into nucleosomes, playing a role in histone deposition during DNA replication as well as transcription-coupled chromatin remodeling. Asf1 binding to H3--H4 also stimulates acetylation of H3K56 in vitro and is required for efficient acetylation of H3K56 in vivo.

We tested which activity of Asf1 is responsible for telomere localization. Asf1 is implicated in nucleosome loading/unloading and chromatin remodeling through its cooperation with other histone chaperones, Hir and CAF-1. If this function of Asf1 is important for telomere localization, disruption of Hir or CAF-1 components should also affect telomere localization. However, disruption of the genes encoding these histone chaperones (*HIR1*, *HIR2*, *RLF2*, *CAC2*, or *MSI1*) had little or no effect on Rap1 organization (Table S1), which suggests that neither Hir nor CAF-1 is crucial for telomere localization. We cannot, however, exclude the possibility that redundant function of CAF-1 and Rtt106 in loading H3--H4 into nucleosomes ([@bib36]) masked an involvement of these histone chaperones in Rap1 organization.

We next tested the alternative possibility that acetylation of H3K56 is required for telomere localization. The *RTT109* gene encodes a histone acetyltransferase responsible for acetylation of H3K56 in vivo ([@bib54]; [@bib13]; [@bib25]; [@bib62]). Both in vivo and in vitro studies confirmed that Asf1 dramatically stimulates the catalytic activity of Rtt109. If H3K56 acetylation is important for telomere localization, telomere localization will be compromised in the *rtt109*Δ mutant, which is deficient for H3K56 acetylation. As shown in [Fig. 4](#fig4){ref-type="fig"}, we found using the chromosome dot assay that the *rtt109*Δ mutant exhibits a severe telomere localization defect for all telomeres tested (telomeres XIV-L, VI-R, and VIII-L; [Fig. 4, A and B](#fig4){ref-type="fig"}). Interestingly, the defect of *rtt109*Δ was cell cycle--independent, in contrast to the S phase--specific defect of the *asf1*Δ mutant. This discrepancy suggests the possibility that Asf1-dependent acetylation of H3K56 is responsible for telomere localization only in S phase, whereas another protein with similar activity could play a role in localization during G1 phase. The *VPS75* gene encodes a recently identified histone H3--H4 chaperone ([@bib55]). In vitro studies demonstrated that, like Asf1, Vps75 can stimulate acetylation of H3K56 by Rtt109 ([@bib26]; [@bib62]). Hence, Vps75 is a candidate for a G1 phase--specific counterpart of Asf1. We tested whether Vps75 is involved in telomere localization. A *vps75*Δ single mutant showed no detectable telomere localization defect, which demonstrates that *VPS75* is dispensable for telomere localization in the presence of *ASF1* ([Fig. 4 A](#fig4){ref-type="fig"}). We investigated whether Asf1 and Vps75 might play redundant roles in telomere localization during G1 phase. Consistent with this idea, an *asf1*Δ *vps75*Δ double mutant showed a severe telomere localization defect in both G1 and S phases, essentially recapitulating the phenotype of *rtt109*Δ ([Fig. 4 A](#fig4){ref-type="fig"}). To summarize, we found that Asf1 and Vps75 function redundantly in telomere localization during G1 phase, whereas only Asf1 can mediate correct telomere localization during S phase.

![**Histone acetyltransferase Rtt109 and histone chaperones Asf1 and Vps75 are crucial for telomere localization.** (A) Localization of telomere XIV-L was tested as in [Fig. 2](#fig2){ref-type="fig"}. Strains used were GA-1985 (WT), SHY196 (*rtt109*Δ), SHY173 (*asf1*Δ), SHY227 (*vps75*Δ), and SHY229 (*asf1*Δ *vps75*Δ). (B) Localization of telomeres VI-R and VIII-L was tested as in [Fig. 2](#fig2){ref-type="fig"}. Strains used were GA-1459 (WT) and SHY298 (*rtt109*Δ) for telomere VI-R, and GA-1986 (WT) and SHY299 (*rtt109*Δ) for telomere VIII-L. Error bars represent SD of values obtained from independent strain isolates (*n* = 4 for *asf1*Δ *vps75*Δ strain, *n* = 3 for *rtt109*Δ strain in A, *n* = 2 for others). WT and random localization values are indicated by blue and red lines, respectively.](jcb1830641f04){#fig4}

Acetylation of H3K56 is crucial for telomere localization
---------------------------------------------------------

To assess the importance of H3K56 in telomere localization directly, we examined the competence for telomere localization of mutants where H3K56 is substituted by the nonacetylatable residue arginine (K56R) or glutamine (K56Q), which may mimic constitutive acetylation ([@bib32]; [@bib40]; [@bib45]; [@bib65]). We found that telomere localization was almost completely disrupted in either mutant in both G1 and S phases, with telomere XIV-L showing virtually random localization within the nuclear space ([Fig. 5](#fig5){ref-type="fig"}). This defect is very similar to the telomere localization defects observed for the *rtt109*Δ mutant and *asf1*Δ *vps75*Δ mutants ([Fig. 4](#fig4){ref-type="fig"}). The fact that the K56Q shows a very similar defect as the K56R mutant ([Fig. 5](#fig5){ref-type="fig"}) suggests that constitutively acetylated or deacetylated H3K56 would not support telomere localization. Together, these results demonstrate that both acetylation and deacetylation of H3K56 are crucial for telomere localization to the nuclear periphery. The effect of H3K56 acetylation in telomere localization appears to be rather specific because deleting components of other histone-modifying enzymes (including components of the ADA and NuA3 histone acetyltransferase complexes, the SAS complexes, and the SET3 histone deacetylase complex) caused little or no Rap1 organization defect (Table S1).

![**Acetylation of H3K56 is crucial for telomere localization.** Localization of telomere XIV-L (GFP-tagged 19 kb from telomere) in WT, K56R, and K56Q strains was tested as in [Fig. 2](#fig2){ref-type="fig"}. (left) Telomere localization in strains carrying either WT histone H3 allele (SHY248) or K56R allele (SHY247). (right) Telomere localization in strains with either a WT histone H3 allele (SHY310) or K56Q allele (SHY304). Histones H3 and H4 are encoded by only one gene in each strain. Error bars represent SD of values obtained from independent strain isolates (*n* = 2). Note that the "% zone 1" values shown here for telomere XIV-L are not directly comparable with the other figures because the GFP-tagged locus is different. WT and random localization values are indicated by blue and red lines, respectively. The difference in WT values between left and right panels is presumably caused by the different strain constructs used.](jcb1830641f05){#fig5}

Peripheral positioning of the *ETC6* chromosome locus
-----------------------------------------------------

We wished to test whether the effect of H3K56 acetylation on chromatin intranuclear positioning is limited to telomeres, or whether instead other chromosome loci require the same histone modification for peripheral positioning. In the fission yeast *S. pombe*, COC sites have recently been identified that associate with the nuclear periphery. COC sites were discovered via a genome-wide chromatin immunoprecipitation analysis of locations bound by transcription factor IIIC (TFIIIC; [@bib44]). Several sites were identified that bind TFIIIC but not its cognate polymerase (RNA Pol III), and these TFIIIC-bound loci were shown to localize to the nuclear periphery. Their perinuclear localization led to the naming of these sequences as COCs. Interestingly, at least one such site serves as a heterochromatin boundary.

Chromosomal sites were previously identified within the budding yeast genome that bind TFIIIC but not RNA Pol III ([@bib41]). These sites are good candidates for *S. cerevisiae* counterparts of the *S. pombe* COC sites. These loci were named extra TFIIIC (*ETC*) sites. We tested whether one of the *ETC* sites, *ETC6*, localizes to the nuclear periphery. *ETC6* lies in a divergent intergene on the right arm of chromosome IV (genome coordinate: IV, 1198690--1199174), more than 300 kb from telomere IV-R ([Fig. 6 A](#fig6){ref-type="fig"}; [@bib41]). We tagged the intergene neighboring *ETC6* using the chromosome dot system and examined its subnuclear localization. As shown in [Fig. 6 B](#fig6){ref-type="fig"}, we found that in a WT strain background, the *ETC6* locus is positioned predominantly at the nuclear periphery. The *ETC6* locus is preferentially localized to the nuclear periphery in G1 and S phases, and, indeed, its peripheral positioning persists in G2 phase, showing that the cell cycle regulation of *ETC6* positioning differs from that of telomeres. The *S. cerevisiae* genome therefore contains at least one peripherally positioned chromosome locus equivalent to an *S. pombe* COC. More detailed analysis of the localization of *S. cerevisiae* COC sites will be described elsewhere.

![**Acetylation of H3K56 is crucial for perinuclear localization of *ETC6*.** (A) Strain construct used to test the intranuclear position of *ETC6* (located within *TFC6-ESC2* intergene on chromosome IV). The neighboring intergene (*BCP1*-*TFC6*) was GFP-tagged in WT, *asf1*Δ, and *rtt109*Δ mutant strains. The center of the *lacO* array is 11 kb from the *ETC6* locus. (B) Peripheral localization was tested as in [Fig. 2](#fig2){ref-type="fig"}. Error bars represent SD of values obtained from independent strain isolates (*n* = 3, 2, and 4 for the WT, *asf1*Δ, and *rtt109*Δ strain, respectively). WT and random localization values are indicated by blue and red lines, respectively.](jcb1830641f06){#fig6}

Peripheral positioning of *ETC6* requires H3K56 acetylation
-----------------------------------------------------------

We tested whether Asf1 and H3K56 acetylation are important for perinuclear localization of the *ETC6* locus. We deleted the *ASF1* and *RTT109* genes from the strain illustrated in [Fig. 6 A](#fig6){ref-type="fig"} and examined the effect on *ETC6* localization. Deleting *ASF1* resulted in random positioning of the *ETC6* locus throughout interphase ([Fig. 6 B](#fig6){ref-type="fig"}), showing that Asf1 is required for *ETC6* peripheral localization. This result contrasts with the S phase--specific defect of *asf1*Δ in telomere localization, and suggests that *VPS75* cannot substitute for *ASF1* in perinuclear localization of *ETC6* in any cell cycle phase. In the *rtt109*Δ mutant, peripheral positioning of *ETC6* was also largely ablated, with a slight preference for localization to zone 1 remaining only in G1 phase of the cell cycle. Deletion of *VPS75*, *SIR4*, and *YKU70* had only minor effects on perinuclear localization of the *ETC6* locus (Fig. S2, available at <http://www.jcb.org/cgi/content/full/jcb.200806065/DC1>), which suggests that the function of these genes is not critical for *ETC6* localization, although they may contribute to some extent. Although believed to bind primarily to telomeres and other silenced loci, a role for Ku and Sir in organizing other chromatin domains has been described previously ([@bib61]), and both proteins have been implicated in confining chromatin movement ([@bib16]; [@bib7]).

To summarize, these mutant phenotypes demonstrate that H3K56 acetylation plays a critical role in perinuclear localization of the COC *ETC6*. H3K56 acetylation is therefore crucial to mediate the correct intranuclear positioning of another peripherally localized chromatin domain, in addition to telomeres.

Discussion
==========

We describe here the identification of seven genes that are required for telomere localization to the nuclear periphery. Overall, the components identified fall in three general categories: first, gene products implicated in chromatin structure or assembly, especially during DNA replication (Ctf18, Asf1, and Rrm3); second, gene products already known to localize to telomeres, whose role in telomere localization highlights a previously unrecognized function (Mre11 and Tel1); and third, gene products thought be involved in unrelated process, whose effect on telomere localization may be indirect (Elp4, Pgd1, and Sic1).

Elp4, Pgd1, and Sic1
--------------------

Elp4 is part of the multifunctional Elongator complex, which is a major histone acetyltransferase component of the RNA polymerase II holoenzyme, and acts as well in other processes including tRNA modification ([@bib58]). *PGD1* (also called *MED3*) encodes a subunit of the Mediator global transcriptional cofactor complex, part of the RNA polymerase II holoenzyme that plays an essential role in basal and activated transcription ([@bib43]). Elp4 and Pgd1 may affect telomere localization indirectly, possibly by altering the expression of other genes required for telomere localization, although we cannot exclude the possibility that histone acetylation activity of Elp4 plays a similar role to Rtt109 (see the following paragraphs).

*SIC1* encodes a cyclin-dependent kinase inhibitor that binds B-cyclin--Cdk complexes during G1 phase to restrain Cdk activity ([@bib35]). Once cells enter S phase, Sic1 is rapidly degraded by the proteasome. This previously described function of Sic1 occurs in G1 phase. *SIC1* is, however, required for telomere localization during S phase and not in G1 phase ([Fig. 2](#fig2){ref-type="fig"} and [Table II](#tbl2){ref-type="table"}). Origin initiation and the DNA replication program are disrupted in a *sic1*Δ mutant, as premature activation of Cdk activity driven by B-type cyclin leads to deregulated entry into S phase ([@bib35]). Disengagement of telomeres from the nuclear periphery is caused by telomere replication, which normally occurs late during S phase ([@bib14]). The S phase--specific telomere localization of the *sic1*Δ mutant may therefore result from a derailed replication program, in which telomeres replicate throughout S phase.

Mre11 and Tel1
--------------

Mre11 and Tel1 are both telomere-binding proteins that are required for telomere length regulation. *TEL1* encodes an ATM/ATR-like kinase, whereas Mre11 is a member of heterotrimeric MRX complex (consisting of Mre11, Rad50, and Xrs2) that is involved in telomere protection and length regulation ([@bib3]; [@bib18]). Recent studies demonstrated that Tel1 preferentially binds shorter telomeres in an Mre11-dependent manner ([@bib28]; [@bib51]). These data suggest that they may have coordinated function in recruitment of telomerase to short telomeres. However, the telomere localization phenotypes of *mre11*Δ and *tel1*Δ mutants showed differing cell cycle specificity ([Fig. 2](#fig2){ref-type="fig"} and [Table II](#tbl2){ref-type="table"}), which suggests that their role in telomere localization may be independent of their function in telomere length regulation. Consistently, no direct correlation between telomere length and localization was observed ([Fig. 3](#fig3){ref-type="fig"}).

Ctf18, Rrm3, and Asf1
---------------------

A group of gene products that are implicated in DNA replication were identified as important for telomere positioning. The group consists of Rrm3, Asf1, and Ctf18. Ctf18 is the largest of three subunits specific to the Ctf18--replication factor C--like complex (RLC). As we previously described, all three subunits specific to the Ctf18-RLC (Ctf18, Ctf8, and Dcc1) are required for telomere positioning ([@bib31]). The molecular target of the Ctf18-RLC remains unclear, although Ctf18-RLC is thought to load or unload proteins at replication forks. Rrm3 is also a replication fork component; *RRM3* encodes a DNA helicase that interacts with proliferating cell nuclear antigen ([@bib53]) and promotes passage of replication forks through protein--DNA complexes, including the telomeric nucleoprotein structure ([@bib33]; [@bib39]). Both *ctf18*Δ and *rrm3*Δ mutants show telomere localization defects during G1 phase, despite the fact that their primary function is believed to occur during S phase. Ctf18 and Rrm3 are similar to Asf1 in being mainly implicated in replication-coupled events, and the identification of all three proteins in our telomere-positioning screen suggests that an S phase event is required for proper telomere localization in the subsequent G1 phase.

Asf1 is of particular interest when considering the possibility that the telomere localization mechanism is coupled to DNA replication. Asf1 physically interacts with components of the replication machinery and mediates replication-coupled nucleosome assembly ([@bib42]). Acetylation of chromatin-associated H3K56 is detectable throughout the cell cycle but dramatically increases in S phase because of incorporation of K56-acetylated H3 into chromatin by Asf1 ([@bib40]; [@bib37]; [@bib46]). This "wave" of H3K56 acetylation on chromatin in S phase is reversed by the histone deacetylases Hst3 and Hst4 ([@bib9]; [@bib37]) and at silenced loci by Sir2 ([@bib66]).

We found that the histone chaperones Asf1 and Vps75 play redundant roles in telomere localization during G1 phase. Vps75 can stimulate acetylation of H3K56 efficiently in vitro ([@bib26]; [@bib55]; [@bib62]). Deletion of *VPS75* does not however detectably decrease bulk cellular levels of acetylated H3K56. One possibility is that Vps75 regulates chromatin structure at a limited number of genomic loci, including telomeric regions. Short telomeres in the *vps75*Δ mutant ([@bib3]) but not in *asf1*Δ ([Fig. 3](#fig3){ref-type="fig"}) are consistent with a telomeric function for Vps75. The observation that Vps75 does not substitute for Asf1 in positioning the *ETC6* locus ([Fig. 6 B](#fig6){ref-type="fig"} and Fig. S2) also suggests a telomere-specific role for Vps75 in chromosome organization. It should be noted, however, that although our results clearly show that the H3K56 acetylation cycle is important for telomere positioning, we do not know at which site acetylation matters. Modulation of H3K56 acetylation in telomeric chromatin may be the critical factor, but an alternative possibility is that the acetylation state of a distant chromosomal site affects telomere localization, perhaps indirectly.

Our identification of the role of Asf1 in telomere positioning led to our observation that H3K56 acetylation by Rtt109 is crucial for telomere localization. Lack of H3K56 acetylation resulted in loss of telomere localization both in G1 and S phases ([Fig. 5](#fig5){ref-type="fig"}), despite the fact that H3K56 acetylation is most pronounced after DNA replication. This observation again implies that an event during replication is required for subsequent telomere localization. The histone H3 K56Q and K56R mutants are equally defective for telomere localization, which suggests that the acetylation/deacetylation cycle that occurs after DNA replication is important for positioning (rather than simply the presence of acetylated H3K56). A role for the acetylation/deacetylation cycle is consistent with the observation that H3K56 is in fact hypoacetylated at subtelomeric regions ([@bib66]).

Telomeres are packaged in a heritable heterochromatin structure ([@bib23]; [@bib64]). Like transcriptional silencing, telomere localization status is subject to epigenetic inheritance ([@bib38]). A role for H3K56 acetylation in the epigenetic inheritance of chromatin structure might explain the effect of H3K56 acetylation on telomere and COC site localization. For example, one possibility is that H3K56 acetylation distinguishes "newly synthesized" nucleosomes from "mature" nucleosomes inherited as histone tetrasomes from parental DNA ([@bib1]). New histone H3 is subject to K56 acetylation at the H3--H4 dimer stage of nucleosome assembly. Acetylated H3K56 could be required to ensure correct transmission of other histone modifications (such as N-terminal tail methylations and acetylations) to nucleosomes containing newly synthesized histones. In this model, the inherited nucleosomes, distinguished by absence of H3K56 acetylation, could be used as a template for copying the required modifications. H3K56 is positioned at the entry/exit point of DNA wound around nucleosomes, and acetylation of the residue is suggested to loosen histone--DNA interactions ([@bib40]). Therefore, nucleosomes acetylated at H3K56 may be easily repositioned to allow reorganization of chromatin to achieve a preferred local chromatin structure (e.g., the compact heterochromatin structure close to telomeres), after which deacetylation of H3K56 might "fix" the chromatin status. In this way, the acetylation/deacetylation cycle of H3K56 could be envisaged to be critical for setting up a particular chromatin status (at telomeres \[[@bib66]\] and other chromosome loci including COC sites) that allows correct localization to the nuclear periphery in the ensuing cell cycle. An early study found that deacetylation of histone is required for maturation of newly replicated chromatin in HeLa cells ([@bib2]), which suggests that such an acetylation/deacetylation cycle may establish chromatin status in mammalian cells.

In this model, the *ctf18*Δ and *rrm3*Δ mutations could be envisaged to affect telomere positioning by affecting replication fork progression in a way that interferes with chromatin establishment, for example, by disrupting the balance between K56-acetylated and nonacetylated H3 on newly synthesized DNA.

The model we outline represents one possible route by which Asf1-stimulated H3K56 acetylation might be important for positioning chromosome domains. Further investigations will of course be necessary to understand how Asf1 and other components identified here regulate the correct organization of chromosomes within the nuclear interior.

Materials and methods
=====================

Yeast strains and plasmids
--------------------------

For screening of Rap1 organization mutants, deletion mutants were picked from the Saccharomyces Genome Deletion Project ([@bib19]) and transformed with plasmid YCp-GFP-RAP1 ([@bib31]). For the genes tested, refer to Table S1. Strains used only for screening are not listed individually; all other strains used are listed in Table S3 (available at <http://www.jcb.org/cgi/content/full/jcb.200806065/DC1>).

The *VPS75* open reading frame (ORF) overlaps with the flanking *CWC25* ORF by one base pair. To avoid interfering with *CWC25* expression, we removed the N-terminal 825 bases of the 890-bp *VPS75* ORF, rather than removing entire coding sequence. To construct strain SHY227, the 826 bases of *VPS75* gene in strain GA-1985 were replaced with the *natMX4* cassette of the plasmid pAG25 ([@bib21]) by one-step gene replacement. The *ASF1* gene of SHY227 was further replaced by *kanMX4* to construct SHY229.

To tag the *ETC6* locus with *GFP*, the *lacO* array of plasmid pAFS52 ([@bib57]) was integrated into the intergene between *BCP1* and *TFC6* in the strain GA-1320 ([@bib30]) to create SBY1, SBY2, and SBY6.

To construct strain SHY234, the mating type of HMY57 ([@bib40]) was converted to *MAT*α by expressing *HO* endonuclease transiently from the plasmid pJH132 ([@bib11]), followed by integration of pSH114 (carrying a *lacO* array) 19 kb from the left end of chromosome XIV (identical to the insertion locus used in [@bib7]). GFP-*lacI* (pAFS135) was integrated at the *HIS3* locus. Strains SHY247 and SHY248 were made by crossing SHY234 to HMY140 or HMY152 ([@bib40]), respectively, followed by transformation with pSH115, which carries the GFP-*NUP49* fusion gene.

HMY133 and HMY135 ([@bib40]) were crossed to SHY296.2 to construct SHY310 and SHY304, respectively.

Other deletion mutant strains were derived from GA-1459 (GFP tagged at 14 kb away from telomere VI-R), GA-1985 (19 kb from VIII-L), GA-1986 (11 kb from telomere XIV-L) ([@bib29]), and SBY1 by replacing the genes of interest with *kanMX4*-disrupted alleles unless otherwise noted. *kanMX4*-disrupted alleles were obtained by PCR amplification of a suitable DNA fragment from the relevant mutant in the *S. cerevisiae* deletion collection ([@bib19]).

Plasmids used are listed in Table S4 (available at <http://www.jcb.org/cgi/content/full/jcb.200806065/DC1>). Plasmid pSH114 was constructed by cloning a PCR-amplified genomic fragment (coordinate XIV: 18,831--19,853) into pAFS59, followed by replacing the *LEU2* marker with the *ADE2* gene from plasmid pGVH30.

The plasmid pSH115 was constructed by recloning the GFP-NUP49 fusion gene of the plasmid pUN100-GFP-NUP49 ([@bib4]) into YCplac33 ([@bib20]).

Cytological techniques
----------------------

Microscopic images were acquired by using a microscope (Deltavision RT; Applied Precision, LLC) with a UPlan-Apo 100× objective (1.35 NA; Olympus) and a cooled charge-coupled device camera (CoolSnap HQ monochrome; Photometrics). The acquisition software used was SoftWoRx (Applied Precision, LLC). The pixel size of acquired images is 66.3 nm under these conditions. Living yeast cells (grown at 30°C) were mounted on 1.7% agarose pad containing appropriate synthetic medium after brief sonication and observed at RT (23°C). For observation of GFP(S65T) fluorescence, an FITC filter set was used to capture z stacks containing 20 images at 250-nm intervals. Differential interference contrast images acquired at the same z intervals were used for determination of cell cycle stage by bud size (see the following paragraph). SoftWoRx explorer (Applied Precision, LLC) was used for subsequent measurements.

The cell cycle stage of individual cells was estimated from bud size: G1 phase, unbudded; S phase, cells with bud smaller than or equal to 2 μm; G2 phase, cells with bud larger than 2 μm and a spherical (i.e., nonmitotic) nucleus.

Quantitative evaluation of telomere localization was performed as described previously ([@bib59]). In brief, yeast cells whose GFP dot is in any of three equatorial sections of the nucleus were chosen for counting. Localization of the GFP dot was scored in two dimensions against three imaginary concentric zones at the equatorial plane, as shown in [Fig. 2 B](#fig2){ref-type="fig"}. At least 100 cells were scored in each culture unless otherwise noted. P-values were calculated by χ^2^ test against either random distribution or WT values.

Telomere length assay
---------------------

XhoI-digested genomic DNA was separated by 1.5% agarose gel electrophoresis in 1× Tris/Borate/EDTA buffer and blotted to neutral nylon membrane (MP Biomedicals) by capillary transfer. The telomeric TG~1-3~ sequence was probed with a radioactively labeled 0.1-kb BamHI--EcoRI fragment from the plasmid pVII-L-URA3-TEL ([@bib24]). Images were acquired by using a phosphorimager (FLA-3000) and analyzed by using ImageGauge software (both from Fujifilm).

Online supplemental material
----------------------------

Table S1 shows the results of the primary screening using the GFP-Rap1 fusion construct. Table S2 shows the result of the secondary screen testing telomere localization by using chromosomal dot strains. Table S3 shows a list of yeast strains. Table S4 shows plasmids used in this study. Fig. S1 shows the telomere length study that is supplementary to [Fig. 3](#fig3){ref-type="fig"}. Fig. S2 shows the analysis of the perinuclear localization of *ETC6* in additional mutant strains. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200806065/DC1>.
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